Screening Colonoscopy That Becomes Therapeutic - Two Payers, Two Answers
A 58-year-old woman whose mother had colon cancer at age 52 presents for a screening colonoscopy; she has no symptoms, no anemia, and no prior polyps. The gastroenterologist reaches the cecum. In the transverse colon he cold-snares a 6-mm sessile polyp. In the sigmoid he hot-snares a 12-mm polyp. In the rectum he takes a forceps biopsy of a small nodule. Pathology returns tubular adenoma for both polyps and benign mucosa for the biopsy. The patient has Medicare Part B with no secondary coverage. The practice's first claim reported two units of the snare polypectomy code with diagnosis Z12.11 as the only diagnosis and was denied as "procedure inconsistent with diagnosis."
1. Build the correct Medicare claim: CPT codes, modifiers, units, and diagnosis sequencing.
Read the worked answer
Claim lines:
- 45385-PT × 1 - colonoscopy with removal of polyp(s) by snare technique
- 45380-59 × 1 - colonoscopy with biopsy (rectal nodule)
- Diagnosis line 1: Z12.11 (encounter for screening for malignant neoplasm of colon)
- Diagnosis line 2: polyp codes for the transverse and sigmoid adenomas (e.g., D12.4, D12.5)
Reasoning:
- Both snare polypectomies collapse into one 45385. CPT directs that when multiple polyps are removed by the same technique in the same session, report a single code. Billing two units was the wrong instinct - units do not track polyp count.
- The rectal forceps biopsy is a different technique, so 45380 is separately reportable with modifier 59 (or XS) to bypass the bundling edit.
- Modifier PT tells Medicare the screening converted to a therapeutic procedure. Keeping Z12.11 first-listed preserves the screening benefit and avoids cost-sharing the patient should not owe; the polyp findings go on subsequent lines. This is exactly why the original claim failed - the payer saw a therapeutic code with a screening-only diagnosis and no PT.
- If the patient had a personal history of polyps, the screening code would change (Z86.010), not disappear.
2. The billing manager says, "We'll just resubmit the same codes with the polyp diagnosis first and add modifier 33, like we do for the Blue Cross patients." Evaluate that plan.
Read the worked answer
Reject it for Medicare. Modifier 33 is not the Medicare mechanism for a screening colonoscopy that converts; PT is. Adding 33 to a Medicare claim with a polyp-first diagnosis removes the screening benefit, shifts the service into the diagnostic deductible/coinsurance bucket, and contradicts the very modifier on the line. It may also look like modifier stacking to an auditor.
For a commercial payer, the analysis genuinely differs: most follow the CPT/AMA convention of appending modifier 33 to the therapeutic colonoscopy and keeping the screening diagnosis first-listed, with findings secondary. But plans vary - some commercial policies want the polyp diagnosis primary and no 33 at all - so the practice must verify each contract's policy rather than applying one rule to all books.
The teachable point: the same clinical event legitimately produces different claim structures by payer. The mistake is not choosing 33 over PT; it is choosing by habit instead of by the payer's written policy, then compounding it with a diagnosis order that undercuts the modifier.